Sato Pharmaceutical Co., Ltd
Sato Pharmaceutical Co., Ltd appears in FDA public data with 1 recall, 0 510(k) clearances, 6 FDA inspections, and 2 compliance actions on record. Its most recent recall (D-0298-2026, Class II) was initiated on December 19, 2025.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 6
- Compliance Actions
- 2
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0298-2026 | Class II | INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count | December 19, 2025 |